CORE LABORATORY
Don't have an account? Sign Up

 

 

Communication strategy Transition guide

 

COMMUNICATION STRATEGY

 

Early and frequent communication with key stakeholders can help ease the adoption of new hematology analyzer in your organization. As part of your communication strategy, begin by identifying major stakeholders and how they will be impacted by the transition to new technology from your current system. Additionally, consider any ways in which your organization can mitigate negative impacts to these stakeholders.

 

A stakeholder mapping exercise may help you in identifying these key individuals, what’s important to them, important points to communicate to set appropriate expectations, communication channel and the frequency of communication. A sample template, with considerations for various stakeholders, is provided in the table below. Even before executing the targeted communication plan, it may be appropriate to announce the laboratory’s plan to transition to a new analyzer in collaboration with the hospital public relations (PR) department and communicate via social media, the hospital newsletter, or other internal channels to ensure overall awareness of the upcoming change.

 

Stakeholder
Care abouts
Communication points
Communicatiton channel
Frequency of communication
Communication lead
 

Medical Technologists

• Impact on workflow
• System operation and performance
• Implementation plan
• Technology differences and similarities
• Staff meeting
• In person workshops and demos
WeeklyProject lead
Laboratory Managers• Impact on laboratory efficiency
• Clinical performance
• Workflow and KPI considerations
• SOP updates
• Staff meeting
• In person workshops and demos
WeeklyProject lead
IT• Compatibility with LIS and middleware• Provide connectivity requirements• In person planning meetingWeekly, through integrationIT represenative
Pathologists• Clinical performance• Provide an update on changes to nomenclature for available parameters / flags
• Discuss any revisions to reference ranges
• Generate evaluation data and review results
• Review any new annotation requirements
• Provide progress updates and go-live date
• Interdepartmental memo
• Medical staff ground rounds
As needed, continuous, post implementationProgram lead

 

KEY TAKEAWAYS

Perform a key stakeholder analysis prior to the start of installation and integration

Develop and execute a comprehensive communication plan that will help ease the transition to new analyzer

COMING NEXT

Section 3: Technology Compatibility Assessment

In this section you will learn how to plan for connectivity and compatibility with the Laboratory Information System (LIS) or middleware upfront to avoid issues later during the implementation and installation of your hematology system.
ADD TO LEARNING PLAN
©2021 Abbott, Abbott Park, Illinois, U.S.A.

Privacy Policy| Terms and Conditions

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

All Alinity hq, CELL-DYN Ruby and CELL-DYN Sapphire instruments are Class I laser products. ACCELERATOR a3600 is a Class II laser product. 

The Alinity, ACCELERATOR and CELL-DYN systems are intended for performing in vitro diagnostic assays on samples of human origin (blood, urine). Read the instructions in the system manuals and labeling and/or reagent instructions carefully. Manufacturer or Authorized Representative: Abbott Germany.

Alinity h-series is available in select countries, not including the US.